PYC 0.00% 10.0¢ pyc therapeutics limited

Ann: Q3 Investor Call Presentation, page-16

  1. 5,890 Posts.
    lightbulb Created with Sketch. 17584
    For those interested, the podcast linked below, The Importance of Collaboration Between Academia and the Biotech Industry, has an interview with Prof. Sue Fletcher and talks about her work with PYC.

    Although dated 20 September 2023, it seems to have been recorded some time earlier.

    Sue Fletcher has recently retired as CSO at PYC and now sits on the PYC Scientific Advisory Board. She has also retired from her position as Senior Principal Research Fellow at Murdoch University. Sue is said to be continuing to work with collaborators, and her team at Murdoch University, to develop antisense therapeutics for rare diseases, with a focus on motor neuron disease.

    https://www.thermofisher.com/blog/b...on-between-academia-and-the-biotech-industry/

    https://www.mq.edu.au/research/rese...motor-neuron-disease-research/conference-2023
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
0.000(0.00%)
Mkt cap ! $466.6M
Open High Low Value Volume
10.0¢ 10.5¢ 10.0¢ $6.07K 60.47K

Buyers (Bids)

No. Vol. Price($)
12 1836604 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 1053833 7
View Market Depth
Last trade - 13.20pm 30/07/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.